Product Information
BENAZEPRIL HCL 40 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1004 per EA under NDC 65862011801. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on May 22, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Benazepril Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
40 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862011801
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
BENAZEPRIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078212FDA Approved
5/22/2008
TE Code
AB
On Market Since
5/22/2008
Pharmacological Classes
Price Statistics
The NADAC for BENAZEPRIL HCL 40 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 48.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1004 per EA |
|---|---|
| All-time high | $0.1318 (Dec 15, 2021) |
| All-time low | $0.0578 (Jan 23, 2019) |
| 52-week high | $0.1004 |
| 52-week low | $0.0955 |
| Median price | $0.0854 |
| Average price | $0.0841 |
| Largest weekly change | +32.8% (Apr 17, 2019) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BENAZEPRIL HCL 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BENAZEPRIL HCL 40 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.1004 per EA (NDC 65862011801), effective Aug 19, 2026.
How has the price of BENAZEPRIL HCL 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for BENAZEPRIL HCL 40 MG TABLET has risen 48.3%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for BENAZEPRIL HCL 40 MG TABLET?
Since Nov 28, 2013, the NADAC for BENAZEPRIL HCL 40 MG TABLET has ranged from a low of $0.0578 (Jan 23, 2019) to a high of $0.1318 (Dec 15, 2021), with a median of $0.0854 per EA.
Are there cheaper alternatives to BENAZEPRIL HCL 40 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BENAZEPRIL HCL 40 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures BENAZEPRIL HCL 40 MG TABLET?
BENAZEPRIL HCL 40 MG TABLET (NDC 65862011801) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.